Standard care plus IV tranexamic acid vs placebo or usual care
Maternal mortality ‐ not reported · women with primary postpartum haemorrhage following vaginal or caesarean birth
Standard care plus IV tranexamic acid showed no clear difference in maternal mortality (all causes) compared with placebo or standard care alone (moderate certainty).
1 finding from 1 review
- Antifibrinolytic drugs for treating primary postpartum haemorrhage 2018 · Cochrane Headline outcomes onlyRR 0.88 [0.74, 1.05]2 studies · 20172 participantsModerate